Amorphous Pharmaceutical Materials 2010

Due to the continuous increase in the number of insoluble developmental drug molecules and growing regulatory scrutiny over pharmaceutical solids, the amorphous pharmaceutical materials have gained importance in the last few years. With the help of interactive discussions, leading presentations, participants will gain a comprehensive outlook of the current market trends, and discover the latest technological developments.

Reasons to register today:
Understand the use of isothermal calorimetry to characterise stability of amorphous pharmaceuticals
Implement the latest technological developments
Discuss the best approaches to control and stabilise amorphous drug forms
Examine the quantification of amorphous content
Gain a clearer insight on amorphous food materials
Seize this opportunity to network with leaders from pharma-biotech, healthcare and regulatory agencies